Cargando…
SUN-412 A Unique Case of Isolated ACTH Deficiency Caused by Pembrolizumab
Background: The anti-programmed-death-receptor-1 (PD-1) antibody, pembrolizumab, is one of the key immunomodulators for different types of refractory cancers. It is known to cause a variety of endocrinopathies including hypothyroidism, hyperthyroidism, diabetes mellitus, hypophysitis and primary adr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553144/ http://dx.doi.org/10.1210/js.2019-SUN-412 |